Creative Medical Technology Holdings, Inc. Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage
Creative Medical Technology Holdings, Inc. (CELZ) reported Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage of 30.00% for the 0-month period ending 2022-02-09, per its 10-K filed 2022-03-30.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage · last filed 2022-03-30
- 2022-02-09: Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 0 month 30.00%.
| Period end | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 0 month |
|---|---|
| 2022-02-09 | 30.00% 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |